Cibinqo (abrocitinib)

pCPA File Number: 21987

Negotiation Status:

Under consideration for negotiation

Indication(s):

moderate to severe atopic dermatitis

Sponsor/Manufacturer:

Pfizer Canada ULC

CADTH Project Number:

SR0686

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable